Reprieve Cardiovascular

MA - Milford

Biotechnology

Focus: Heart Failure Fluid Management

Reprieve Cardiovascular is a life sciences company focused on Heart Failure Fluid Management.

CardiovascularMetabolic Diseases

Funding Stage

SERIES B

Open Jobs

Pipeline & Clinical Trials

Fluid Management

N/A

Clinical Trials (1)

NCT05015764Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study

N/A

Reprieve Decongestion Management System

N/A

Clinical Trials (1)

NCT05174312Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

N/A

Reprieve Decongestion Management System

N/A

Clinical Trials (1)

NCT06362668EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)

N/A

Reprieve System

N/A

Clinical Trials (1)

NCT06272734Reprieve System Pilot Study

N/A

Reprieve System

Phase 3

Clinical Trials (1)

NCT06898515Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Phase 3

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 5 clinical trials